http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2056894-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3e9445e5e3626f36e932c6451a928250 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-425 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-426 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-425 |
| filingDate | 1991-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a7ec28e82096e41c1ba52c681e8105c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1039af9ef05c5dab30be1dc3906488aa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb6fa24596a7a1be5f2eee9cf0fcae66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_640c2907ee5a26a27e089252e450d814 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08888eacce142424290285817a1866e2 |
| publicationDate | 1992-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2056894-A1 |
| titleOfInvention | Use of carbazones as novel active ingredients in medicaments |
| abstract | The use of carbazones as novel active ingredients in medicaments Abstract of the Disclosure Compounds of formula I (I), wherein X and Y are each independently of the other thio or sulfynyl, R1 is lower alk-2-en-l-yl, lower alk-3-en-2-yl, lower alk-2-yn- 1-yl, or lower alkyl that is substituted in the 2,3-position by radicals that can be eliminated to form a double bond, R2 is hydrogen and R3 is unsubstituted methyl or methyl substituted by a radical that can be eliminated together with hydrogen R2 to form a double bond, or R2 and R3 are each hydrogen or lower alkyl or together are methylene, R4 is free or protected hydroxy, or hydrogen, and R5 is hydrogen, lower alkyl, lower alk-2-en-1-yl, lower alk-2-yn-1-yl, or lower alkyl that is substituted in the 2,3-position by radicals that can be eliminated to form a double bond, and their pharmaceutically acceptable salts may be used in a novel manner for the treatment of disorders of the rheumatoid type. |
| priorityDate | 1990-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 91.